BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34116288)

  • 1. Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.
    Zhang S; Liu N; Ma M; Huang H; Handley M; Bai X; Shan F
    Int Immunopharmacol; 2021 Sep; 98():107837. PubMed ID: 34116288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
    Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
    Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
    Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.
    Ma M; Wang X; Liu N; Shan F; Feng Y
    Int Immunopharmacol; 2020 Jun; 83():106388. PubMed ID: 32171145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma.
    Bai X; Shan F; Qu N; Huang H; Handley M; Griffin N; Zhang S; Cao X
    Int Immunopharmacol; 2021 Oct; 99():107996. PubMed ID: 34311187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine enkephalin, its role in immunoregulation and cancer therapy.
    Zhao D; Plotnikoff N; Griffin N; Song T; Shan F
    Int Immunopharmacol; 2016 Aug; 37():59-64. PubMed ID: 26927200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin.
    Wang X; Tian J; Jiao X; Geng J; Wang R; Liu N; Gao X; Griffin N; Gao Y; Shan F
    Cancer Manag Res; 2018; 10():4773-4787. PubMed ID: 30425572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.
    Lu WC; Xie H; Tie XX; Wang R; Wu AH; Shan FP
    Int Immunopharmacol; 2018 Mar; 56():1-8. PubMed ID: 29324390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
    Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
    Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
    Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
    Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
    Jiang H; Zhao PJ; Su D; Feng J; Ma SL
    Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
    Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer.
    Zhang X; Wang D; Li Z; Jiao D; Jin L; Cong J; Zheng X; Xu L
    Front Immunol; 2020; 11():331. PubMed ID: 32161598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gypenosides induces apoptosis in human non-small-cell lung cancer A549 cells via increasing the Bax/Bcl-2 ratio, caspase-3 and suppressing the NF-κB.
    Li X; Liang L; Yu D; Fu H; Mo Z; Wang Y
    Panminerva Med; 2021 Mar; 63(1):94-95. PubMed ID: 31352758
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
    Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
    J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbon reduces cell damage from blast injury by inhibiting signal paths of NF-κB, MAPK and Bcl-2/Bax signaling pathway in A549 cells.
    Zhang Z; Liang Z; Li H; Li C; Yang Z; Li Y; She D; Cao L; Wang W; Liu C; Chen L
    PLoS One; 2017; 12(3):e0173884. PubMed ID: 28323898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways.
    Lu ZJ; Zhou Y; Song Q; Qin Z; Zhang H; Zhou YJ; Gou LT; Yang JL; Luo F
    Cell Physiol Biochem; 2010; 26(4-5):609-18. PubMed ID: 21063098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.